Carrington's DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
New Patent Expands Geographic Coverage IRVING, Texas, Feb. 11 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that the Eurasian Patent Office has granted patent application No. 200600484, titled "Delivery of Physiological Agen...Carrington's DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th
IRVING, Texas, Nov. 5 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today said the upcoming presentation on DelSite Biotechnologies, Inc., its wholly-owned subsidiary, will be webcast live from the Kennedy I Room at the Acumen BioFin Rodman & Renshaw 9th An...Carrington Subsidiary DelSite to Present at Investor Conference
IRVING, Texas, Nov. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced that DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, N...Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
Key Presentation by Dr. Yawei Ni, DelSite's CSO, Will Detail Antigen Sparing and Immunoenhancing Attributes of GelSite(R) Polymer IRVING, Texas, Oct. 3 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) today announced that Dr. Yawei Ni, Chief Scientific Officer...DelSite Chairman George DeMott Resigns
...nto a vaccine and drug delivery company. delsite Biotechnologies, Inc (DSBI) was established as a w...es to DelSite, Inc. in June of this year. delsite continues to transition itself into a more traditi...antigen. I believe the four platforms developed by delsite are based on state-of-the-art science. Several col...Nosespray vaccine using aloe vera has exciting potential, researcher says
... Veterinary Medicine & Biomedical Sciences. The project is funded in part by a $6 million grant from the National Institutes of Health awarded to delsite Biotechnologies in conjunction with the Texas A&M teams. DelSite, an Irving-based company, has a facility in College Station. Tizard says the metho...DelSite Working Toward Solving Delivery of Influenza Vaccine in Pandemic Situations
... IRVING, Texas, Officials of delsite Biotechnologies, Inc., a wholly-owned subsidiary of Carrington Laboratories, Inc. said the company's novel powder-based vaccine delivery technology m...Carrington Reports 2007 Financial Results
... 2007. Excluding net funding of $2.8 million for delsite Biotechnologies, Inc., the Company's wholly-owned ... 2007 was $7.0 million. 2006's net loss, including delsite net costs of $3.1 million, was $7.6 million, or ($... being developed by DelSite. As previously stated, delsite is currently engaged in the cGMP manufacture of th...Carrington and Universal Harvest Sign Supply Agreement
...and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) polymer technology designed to provide controlled release of peptide and protein-b...Carrington Settles Lawsuit, Sets Sights On Future
...glad to put this lawsuit behind us without significant financial impact." delsite Biotechnologies, Inc., is Carrington's wholly owned subsidiary that is deve...ompanies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) technol...Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
...and markets consumer products and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its proprietary GelSite(R) polymer technology designed to provide controlled release of peptide and protein-b...GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
...Board: CARN) today announced that its wholly owned delsite Biotechnologies, Inc. subsidiary has successfully ...to normal FDA regulatory procedures. Separately, delsite successfully completed its second pre-IND meeting ...out DelSite Carrington's wholly owned subsidiary delsite Biotechnologies, Inc. is developing its proprietar...DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
... An experimental drug delivery technology from the delsite Biotechnologies subsidiary of Carrington Laborator...FC). The new vaccine technology from Texas-based delsite is the first of its class to eliminate the need fo...perations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its propr...Carrington Reports Third Quarter 2007 Results
...uble Digit Quarter-to-Quarter Revenue Gain - delsite Continues Toward Phase I Vaccine Clinical Trial ...hare. Pro forma loss for the quarter, exclusive of delsite net funding, was $1.7 million compared to a $1.1 m...perations comply with cGMP standards. Carrington's delsite Biotechnologies subsidiary is developing its propr...